Lilly’s Affordable Zepbound Vials: A Game Changer
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
- Latest
- Trending
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
AI-powered translation tools are breaking language barriers, reshaping global communication, and enabling international business growth.
Cyber attack disrupts Seattle airport's systems causing delays. Authorities assess potential data breaches post weekend attack.
Rising living costs force 1 in 4 retirees back to work, challenging the American dream due to financial struggles.
Join industry leaders Nov 18-19 at IISc Bengaluru to explore the future of construction technology at CTD 2024.
Ford's EV strategy changes benefit Tesla, Rivian, Lucid by reducing competition and opening market opportunities.
Ireland's NEG8 Carbon enhances DAC with cost-effective innovations, reducing energy use and boosting CO2 capture efficiency.
Discover how VR is transforming online gaming with immersive experiences and social interactions.
Target's Q2 surpasses expectations with a 42% EPS boost, driven by consumer traffic and digital channel success.
Ark Labs raises $2.5M to enhance bitcoin transaction speed and cost efficiency, led by investor Tim Draper.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.